Navigation Links
Ingenuity Systems and Covance Collaborate to Support Next-Generation Sequencing Research

REDWOOD CITY, Calif., Feb. 23, 2011 /PRNewswire/ -- Ingenuity® Systems, a leading provider of information and analytics solutions for life science researchers, today announced a research collaboration with Covance Genomics Laboratory ( for next-generation sequencing (NGS) data analysis. Covance Genomics Laboratory, a leading provider of genomics solutions for the drug discovery and development industry, and Ingenuity will work together to develop new and novel approaches, using Ingenuity's IPA® software, to obtain more actionable insights from NGS data and to answer research questions in a relevant biological context.

This collaboration brings together leaders in genomics data production and analysis to develop new methodologies that integrate high-quality NGS data with industry-leading knowledge generation and management tools.  By working together to generate the next generation of biological interpretation tools, Covance Genomics Laboratory will have the unique ability to help its pharmaceutical clients maximize the value of their investment in NGS technologies.  IPA relieves the NGS data analysis bottleneck by providing the biological context necessary to move past the long noisy lists of genes, isoforms, and variants, helping to uncover those that are most critical to biology.  This enables researchers to quickly get to the intended high-value results of biomarker identification, target ID and validation, understanding drug mechanism of action, and safety assessment.

"We're delighted that Covance has selected IPA for its NGS workflows," said Doug Bassett, Ph.D., CSO and CTO, Ingenuity Systems. "We've been involved in several NGS collaborations recently, and our partnership with Covance, a leading drug development services company, represents another powerful validation of IPA's value in the NGS space. It is exciting to see IPA being used to accelerate and inform so much groundbreaking research."

Having run more than 450,000 samples to date, Covance Genomics Laboratory provides end-to-end services for genomics-based development research and has demonstrated particular expertise in NGS.  "The complexity of next-generation sequencing data can be a challenge to translational science and medicine," stated Tom Turi, Vice President, Science & Technology, Covance Discovery & Translational Services. "We're confident the combination of our best-in-class genomics data and the high-quality biological content and context provided by IPA will result in the delivery of more rapid, accurate, and thorough research services for our customers."  

About Ingenuity® Systems

Ingenuity Systems is a leading provider of information solutions and custom services for life science researchers, computational biologists and bioinformaticists, and life science industry suppliers. For more information visit:

SOURCE Ingenuity Systems
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Launches Your Favorite Gene Powered by Ingenuity
2. Sigma-Aldrich Honored With CIO 100 Award for Innovative Web Research Tool, Your Favorite Gene powered by Ingenuity
3. Ingenuitys Technology Powers BD Cell Pathways Tool on New BD Biosciences Website
4. Ingenuity Systems Announces New Distributor for Greece, Turkey and the Balkans
5. Ingenuity Systems Announces Toxicogenomics Best Practices White Paper
6. Ingenuity Systems and Sage Bionetworks Collaborate to Enable Predictive Disease Network Research
7. Ingenuity Systems and Erasmus University Medical Center Collaborate on Next-Generation Sequencing Project to Accelerate Disease Research
8. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
9. North Dakota Pharmacists and Medication Management Systems Partner to Deliver Quality MTM Services to Patients With Diabetes
10. Avantis Medical Systems, Inc. Announces Key Leadership Appointments
11. Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems
Post Your Comments:
(Date:10/11/2017)... , Oct. 11, 2017  VMS BioMarketing, a leading ... a nationwide oncology Clinical Nurse Educator (CNE) network, which will ... need for communication among health care professionals to enhance the ... nurses, office staff, and other health care professionals to help ... breast cancer. ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today ... designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) ... able to cross the cell membrane and bind intracellular STAT3 and inhibit its ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. spent ... entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, 2017 ... joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, Grossmont ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... of 13 prestigious awards honoring scientists who have made outstanding ... a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for ...
Breaking Biology Technology:
(Date:3/30/2017)... KONG , March 30, 2017 The ... a system for three-dimensional (3D) fingerprint identification by adopting ground breaking ... into a new realm of speed and accuracy for use in ... at an affordable cost. ... ...
(Date:3/28/2017)... The report "Video Surveillance Market ... Storage Devices), Software (Video Analytics, VMS), and Service (VSaaS, ... to 2022", published by MarketsandMarkets, the market was valued ... to reach USD 75.64 Billion by 2022, at a ... year considered for the study is 2016 and the ...
(Date:3/24/2017)... , Mar 24, 2017 Research and ... Access System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 15.1% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):